Cochlear | COH - Ebit

Aktienkurs
173.59
Täglich Wechseln
0.52 0.30%
Monatlich
-12.27%
Jährlich
-35.34%
Q1 Prognose
170.76




Ebit Veränderung Datum
Ansell USD 146.5M 29.2M 2025-12
Avita Medical AUD -10.39M 1.72M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Healius AUD 23.7M 26M 2024-12
Integral Diagnostics AUD 24.99M 5.08M 2024-06
Mayne Pharma AUD -16.2M 13.2M 2024-06
Mesoblast USD -27.75M 14.36M 2025-12
Monash IVF AUD 18M 6.11M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Polynovo AUD 840K 147K 2024-06
Ramsay Health Care AUD 541.1M 20.7M 2025-12
Regis Healthcare AUD 24.67M 19.69M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Somnomed AUD -1.99M 83.11K 2023-06
Sonic Healthcare AUD 423.94M 80.3M 2024-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12